Amelie L. Guihot

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Emerging evidence for anti-PD-1 and IFN-γ as adjunctive immunotherapy in invasive mold infections.

Emerging evidence for anti-PD-1 and IFN-γ as adjunctive immunotherapy in invasive mold infections.

Journal: mBio
Published: May 22, 2026

Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma.

Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma.

Journal: Haematologica
Published: March 09, 2026

Opposing Association of Lung Neutrophils and PD-L1+ Monocytes in Age-Related Severity of SARS-CoV-2 Infection.

Opposing Association of Lung Neutrophils and PD-L1+ Monocytes in Age-Related Severity of SARS-CoV-2 Infection.

Journal: Aging cell
Published: February 13, 2026

Coordination of cellular responses to SARS-CoV-2 during severe COVID-19 illness.

Coordination of cellular responses to SARS-CoV-2 during severe COVID-19 illness.

Journal: Immunology letters
Published: August 14, 2025

Consequences of Stopping Antiretroviral Treatment in a Persistently Seronegative Individual with HIV-1.

Consequences of Stopping Antiretroviral Treatment in a Persistently Seronegative Individual with HIV-1.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 15, 2025

CD8 and CD4 CAR-T cells are associated with outcome and toxicity of tisagenlecleucel in central nervous system lymphoma.

CD8 and CD4 CAR-T cells are associated with outcome and toxicity of tisagenlecleucel in central nervous system lymphoma.

Journal: Cytotherapy
Published: February 24, 2025

Soluble CD95L is a prognostic marker in central nervous system posttransplant lymphoproliferative disorders.

Soluble CD95L is a prognostic marker in central nervous system posttransplant lymphoproliferative disorders.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: December 29, 2024

Combined antifungal therapy with immunostimulation for refractory cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus.

Combined antifungal therapy with immunostimulation for refractory cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus.

Journal: Diagnostic microbiology and infectious disease
Published: November 12, 2024

Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC.

Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 27, 2024

Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.

Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.

Journal: Haematologica
Published: September 20, 2023

CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes.

CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes.

Journal: Haematologica
Published: February 23, 2023

Identification of natural killer markers associated with fatal outcome in COVID-19 patients.

Identification of natural killer markers associated with fatal outcome in COVID-19 patients.

Journal: Frontiers in cellular and infection microbiology
Published: February 14, 2023
Showing 1-12 of 62

Last Updated: 09/26/2026